{"gene":"PEG10","run_date":"2026-06-10T05:19:53","timeline":{"discoveries":[{"year":2005,"finding":"Peg10 knockout mice exhibit early embryonic lethality due to severe placental defects, specifically absence of both the spongiotrophoblast and labyrinth layers, establishing PEG10 as essential for placental formation in mammals.","method":"Gene knockout in mice (loss-of-function) with histological phenotypic readout","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean KO with defined embryonic-lethal phenotype, independently referenced across many subsequent papers","pmids":["16341224"],"is_preprint":false},{"year":2001,"finding":"PEG10 encodes two overlapping open reading frames (ORF1 and ORF2) with homology to the Gag and Pol proteins of Ty3/gypsy LTR retrotransposons, establishing it as a retrotransposon-derived domesticated gene.","method":"Sequence analysis of predicted ORFs, genomic localization","journal":"Genomics","confidence":"Medium","confidence_rationale":"Tier 3 / Strong — sequence/bioinformatic identification replicated and validated by multiple subsequent functional studies","pmids":["11318613"],"is_preprint":false},{"year":2007,"finding":"PEG10 undergoes programmed −1 frameshifting during translation with >60% efficiency in developing mouse placenta and amniotic membrane, producing both the ORF1 protein and an ORF1-2 fusion protein. Mutagenesis of the active-site motif (Asp-Ser-Gly) of the putative aspartic protease within ORF2 demonstrated that this enzyme is active and participates in post-translational processing of the ORF1-2 protein.","method":"In vivo frameshifting reporter assay, active-site mutagenesis, protein detection in mouse and human placenta","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vivo frameshift assay combined with active-site mutagenesis in a single rigorous study","pmids":["17942406"],"is_preprint":false},{"year":2003,"finding":"PEG10 protein physically associates with SIAH1 (a mediator of apoptosis), and overexpression of PEG10 decreases SIAH1-mediated cell death, establishing PEG10 as an inhibitor of SIAH1-dependent apoptosis.","method":"Co-immunoprecipitation, overexpression with functional apoptosis assay","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — single Co-IP with functional rescue assay, single lab","pmids":["12810624"],"is_preprint":false},{"year":2006,"finding":"c-MYC directly binds to an E-box-containing region in the PEG10 first intron and activates PEG10 transcription; site-directed mutagenesis of the most proximal E-box abolished promoter activity, placing PEG10 as a direct transcriptional target of MYC.","method":"Chromatin immunoprecipitation (ChIP), RNAi knockdown of MYC, site-directed mutagenesis of E-box","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — ChIP plus mutagenesis plus RNAi in a single study, direct mechanistic demonstration","pmids":["16423995"],"is_preprint":false},{"year":2007,"finding":"Androgen receptor (AR) directly binds to androgen-responsive elements in the promoter and exon 2 regions of the PEG10 gene in hepatoma cells (demonstrated by ChIP), and DHT-stimulated AR activates PEG10 expression to enhance HCC cell growth and apoptotic resistance and upregulate hTERT in a PEG10-dependent manner.","method":"ChIP assay, siRNA knockdown of AR and PEG10, AR transfection into AR-lacking cells, in vivo nude mouse xenograft","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP combined with genetic rescue experiments and in vivo model in a single study","pmids":["17369855"],"is_preprint":false},{"year":2008,"finding":"Transcription factors E2F-1 and E2F-4 directly bind to the PEG10 promoter and regulate its expression, as shown by ChIP; PEG10 is involved in repression of apoptosis induced by serum deprivation and chemotherapeutic drugs.","method":"ChIP, promoter binding assay, functional apoptosis assay","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP with functional follow-up, single lab","pmids":["18625225"],"is_preprint":false},{"year":2017,"finding":"E2F-1 directly enhances PEG10 expression by binding to the PEG10 promoter (shown by ChIP), and PEG10 knockdown causes G0/G1 arrest mediated by p21 and p27 upregulation, and reduces pancreatic cancer cell invasion via the ERK/MMP7 pathway.","method":"ChIP assay, siRNA knockdown, cell cycle and invasion assays","journal":"Journal of experimental & clinical cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus multiple functional assays, single lab","pmids":["28193232"],"is_preprint":false},{"year":2010,"finding":"PEG10 translation is initiated at a non-AUG start codon upstream of the previously predicted AUG codon as well as at the AUG codon, adding a new layer to its translational complexity.","method":"Molecular cloning and mutational analysis of translation start sites, promoter-reporter constructs","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — single lab with direct mutagenesis/reporter, no independent replication","pmids":["20084274"],"is_preprint":false},{"year":2019,"finding":"The Gag domain of PEG10 promotes vesicle budding similar to HIV p24 Gag protein. PEG10 binds to numerous cellular RNAs including Hbegf mRNA, and loss of PEG10 in trophoblast stem cells reduces Hbegf expression and impairs differentiation into placental lineages. PEG10 was identified as a substrate of the deubiquitinating enzyme USP9X.","method":"Vesicle budding assay, RNA immunoprecipitation/proteomics (Verschueren et al.), PEG10-deficient TSC differentiation assay, Co-IP for USP9X interaction","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — multiple orthogonal methods (RNA-IP, vesicle assay, deubiquitinase substrate Co-IP, KO phenotype), single lab","pmids":["30951545"],"is_preprint":false},{"year":2021,"finding":"PEG10 is a mammalian Gag homolog that preferentially binds and facilitates vesicular secretion of its own mRNA via sequences in its 3′ UTR. The mRNA cargo of PEG10 can be reprogrammed by flanking genes of interest with PEG10's untranslated regions, enabling selective endogenous encapsidation for cellular delivery (SEND).","method":"Biochemical purification of virus-like particles, RNA sequencing of particle contents, UTR-flanking reporter assays, functional delivery assays in mouse and human cells","journal":"Science (New York, N.Y.)","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal methods (particle purification, RNA-seq, UTR swap, delivery assays) in a rigorous study with functional validation","pmids":["34413232"],"is_preprint":false},{"year":2021,"finding":"PEG10 protein increase (but not RNA) is dependent on UBE3A and proteasome function; UBE3A loss (as in Angelman syndrome neurons) leads to PEG10 protein accumulation. PEG10 binds to RNA and to ataxia-associated proteins ATXN2 and ATXN10, localizes to stress granules, and is secreted in extracellular vesicles where it modulates vesicle content. Overexpression of PEG10 during mouse brain development alters neuronal migration.","method":"Unbiased proteomics, antisense oligonucleotide modulation of UBE3A, Co-IP for ATXN2/ATXN10, stress granule localization imaging, extracellular vesicle purification, in vivo neuronal migration assay","journal":"Cell reports. Medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (proteomics, Co-IP, imaging, in vivo), disease model context with genetic rescue","pmids":["34467244"],"is_preprint":false},{"year":2021,"finding":"The viral aspartic protease (DSG) motif in the POL-like region (ORF2) of PEG10 is essential for maintenance of fetal capillary structure in mid-to-late gestation placenta. Mice with a mutation in this motif show perinatal lethality with fetal vascular defects, specifically in the three trophoblast layers surrounding fetal capillary endothelial cells where PEG10 is expressed.","method":"Active-site knock-in mutagenesis in mice, histological analysis of placental vasculature, in situ expression localization","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vivo active-site mutagenesis with defined vascular phenotype and localization","pmids":["34559199"],"is_preprint":false},{"year":2020,"finding":"The PEG10 gag-pol protein undergoes retrotransposon-like self-cleavage to generate a liberated 'nucleocapsid' fragment that uniquely localizes to the nucleus and alters expression of genes involved in axon remodeling. UBQLN2 regulates PEG10 gag-pol protein levels in human cells and spinal cord tissue.","method":"Protein fractionation, nuclear localization imaging, gene expression profiling, UBQLN2 knockdown/overexpression","journal":"eLife","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — subcellular fractionation with functional gene expression consequence, UBQLN2 regulation shown in cells and patient tissue","pmids":["36951542"],"is_preprint":false},{"year":2021,"finding":"X-ray crystal structures of a stably folded domain of PEG10 reveal high structural similarity to the C-terminal capsid (CA) domain of cognate Gag proteins from LTR retrotransposons, confirming PEG10 as a domesticated Gag and suggesting possible preservation of capsid-assembly interactions.","method":"X-ray crystallography with structural comparison","journal":"Proteins","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structure with direct structural validation, single study","pmids":["34357660"],"is_preprint":false},{"year":2020,"finding":"The aspartic protease domain of PEG10 ORF1/2 (containing the -Asp-Ser-Gly- active-site motif) is functionally active; overexpression of the ORF1/2 form increases cellular proliferation but also has a detrimental effect on cell viability, while an active-site D370A mutant alters these effects, indicating the protease domain modulates proliferation and viability.","method":"Active-site mutagenesis (D370A), cell transfection, proliferation and viability assays in HEK293T and HaCaT cells","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — active-site mutagenesis with functional cellular readout, single lab","pmids":["32244497"],"is_preprint":false},{"year":2017,"finding":"The menin-MLL1 complex binds the PEG10 promoter and promotes H3K4 methylation to activate PEG10 transcription; pharmacological inhibition of the menin-MLL interaction with MI-503 displaces the complex from the PEG10 promoter, reduces H3K4 methylation, and transcriptionally represses PEG10 in HCC models.","method":"ChIP assay for menin-MLL1 at PEG10 promoter and H3K4me marks, small-molecule inhibitor treatment, in vivo xenograft","journal":"Molecular cancer therapeutics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP with pharmacological perturbation and in vivo confirmation, single lab","pmids":["29142068"],"is_preprint":false},{"year":2016,"finding":"PEG10 is required for TGF-β1-induced epithelial-mesenchymal transition (EMT) in HCC cells; cells with PEG10 knocked down do not undergo EMT upon TGF-β1 stimulation and show reduced migration and invasion. Conversely, TGF-β1 upregulates PEG10 expression, and PEG10 overexpression confers chemoresistance.","method":"Adenoviral shRNA knockdown, overexpression, TGF-β1 stimulation, migration/invasion assays, EMT marker analysis","journal":"Oncology reports","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — multiple functional assays, genetic and pharmacological perturbation, single lab","pmids":["28004118"],"is_preprint":false},{"year":2017,"finding":"PEG10 represses TGF-β and BMP-SMAD signaling pathways (both SMAD2/3 and SMAD1/5/9 branches) in chondrosarcoma cells; PEG10 knockdown increases phospho-SMAD3 and phospho-SMAD1/5/9, and reporter assays show PEG10 directly represses TGF-β and BMP signaling while TGF-β1 in turn suppresses PEG10 expression, establishing a mutually inhibitory relationship.","method":"Luciferase reporter assays for SMAD pathway activity, siRNA knockdown, immunoblotting for phospho-SMADs, microarray","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reporter assays combined with knockdown and signaling readouts, single lab","pmids":["29044189"],"is_preprint":false},{"year":2018,"finding":"PEG10 knockdown in chondrosarcoma cells augments TGF-β1-induced motility via AKT phosphorylation (reversed by AKT inhibitor MK2206), and augments BMP-6-induced invasion via p38 MAPK and AKT pathways and upregulation of MMP-1, -3, and -13, identifying PEG10 as an inhibitor of TGF-β/BMP-driven motility and invasion through these kinase cascades.","method":"siRNA knockdown, AKT and p38 inhibitors, MMP inhibitors, invasion assays, immunoblotting","journal":"Journal of bone and mineral metabolism","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — pathway inhibitor rescue experiments combined with knockdown, multiple functional readouts, single lab","pmids":["30094509"],"is_preprint":false},{"year":2018,"finding":"TSG101 physically interacts with PEG10 and protects it from proteasomal degradation; knockdown of TSG101 reduces PEG10 protein levels and downstream effectors p53, p21, and MMPs, while overexpression has opposite effects.","method":"Co-immunoprecipitation, iTRAQ proteomics, siRNA knockdown, overexpression, immunoblotting","journal":"Journal of cellular and molecular medicine","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — Co-IP plus proteomics plus functional knockdown, single lab","pmids":["30450735"],"is_preprint":false},{"year":2019,"finding":"Activated AR binds to the PEG10 enhancer (confirmed by ChIP assay) and represses PEG10 expression. Antagonism of AR increases PEG10 expression followed by increased neuroendocrine (NE) markers; androgen supplementation reverses this. PEG10 knockdown reduces NE markers and attenuates tumor growth in vitro and in vivo.","method":"ChIP assay, AR agonist/antagonist treatment, siRNA knockdown, in vivo xenograft","journal":"Journal of molecular endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP combined with pharmacological and genetic perturbation, in vivo validation, single lab","pmids":["31013476"],"is_preprint":false},{"year":2021,"finding":"IGF2BP1 recognizes m6A sites in the 3′ UTR of PEG10 mRNA and recruits PABPC1 to enhance PEG10 mRNA stability, consequently increasing PEG10 protein expression; a large proportion of PEG10 protein then binds p16 and p18 gene promoter sequences to repress their expression and accelerate the cell cycle.","method":"RNA-binding protein immunoprecipitation sequencing (RIP-seq), methylated RIP-seq, RNA-seq, Co-immunoprecipitation and mass spectrometry, xenograft","journal":"Theranostics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal omics and biochemical methods, single lab","pmids":["33391523"],"is_preprint":false},{"year":2016,"finding":"miR-122 suppresses PEG10 protein expression via direct binding to the 3′ UTR of the PEG10 transcript (translational repression rather than mRNA degradation), demonstrated by reporter assay; deficiency of miR-122 in knockout mice is associated with increased PEG10 and HCC progression.","method":"Luciferase reporter assay, miR-122 overexpression, miR-122 knockout mouse model, qRT-PCR and western blot","journal":"Journal of translational medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reporter assay with genetic validation in knockout mice, single lab","pmids":["27370270"],"is_preprint":false},{"year":2007,"finding":"peg10 expression is induced early in adipocyte differentiation; peg10 RNAi inhibits 3T3-L1 differentiation into lipid-laden adipocytes, reduces C/EBPβ and C/EBPδ expression, and inhibits mitotic clonal expansion, establishing PEG10 as essential for adipogenesis at the immediate early stage.","method":"RNAi knockdown, adipocyte differentiation assay, gene expression analysis","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — RNAi with defined differentiation phenotype and downstream gene expression readout, single lab","pmids":["17707377"],"is_preprint":false},{"year":2022,"finding":"PEG10 overexpression in cutaneous T-cell lymphoma increases cell size, promotes cell proliferation, and confers treatment resistance via a PEG10/KLF2/NF-κB signaling axis, driven by 7q21.3 amplification in large-cell transformation.","method":"Genomic hybridization, in vitro and in vivo models, pathway analysis (PEG10/KLF2/NF-κB), pharmacological targeting","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro and in vivo models with defined pathway, single lab","pmids":["34582557"],"is_preprint":false},{"year":2024,"finding":"USP9X (a deubiquitinase) interacts with PEG10 and deubiquitinates it, thereby stabilizing PEG10 protein levels. Knockdown or pharmacological inhibition of USP9X leads to downregulation of PEG10 and its downstream pathway in CTCL, and impairs tumor growth in vivo.","method":"Co-immunoprecipitation, ubiquitination assay, USP9X knockdown/inhibitor, in vivo tumor model","journal":"The Journal of investigative dermatology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus ubiquitination assay plus in vivo model, single lab","pmids":["38677662"],"is_preprint":false},{"year":2023,"finding":"UBQLN2 regulates proteasomal degradation of the PEG10 gag-pol protein specifically (not the gag protein). Both forms bind UBQLN2 independently of ubiquitination, but only gag-pol is degraded in a UBQLN2-, ubiquitin-, and proteasome-dependent fashion. Gag-pol ubiquitination is dependent on E3 ubiquitin ligase UBE3A, which requires UBQLN2 to regulate gag-pol levels; mutation of key lysine residues in the pol region renders gag-pol insensitive to UBQLN2.","method":"Co-immunoprecipitation, ubiquitination assay, site-directed mutagenesis of lysine residues, proteasome inhibitor treatment, UBE3A siRNA knockdown","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal biochemical methods (Co-IP, ubiquitination assay, mutagenesis, genetic and pharmacological perturbation) establishing mechanism","pmids":["41234208"],"is_preprint":false},{"year":2026,"finding":"SIAH1 and SIAH2 both bind to the PAIR domain of PEG10 and promote its polyubiquitination, but with opposing functional consequences: SIAH1 mediates K48-linked ubiquitination at Lys36 and K63-linked at Lys170, leading to decreased PEG10 levels and suppression of HCC; SIAH2 mediates K48-linked ubiquitination at Lys36 and K63-linked at Lys19 and Lys155, resulting in net accumulation of PEG10 and promotion of HCC.","method":"Co-immunoprecipitation, ubiquitination assays, site-directed mutagenesis of lysine residues, xenograft models, clinical sample correlation","journal":"Cell communication and signaling","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstitution of ubiquitination with site-specific mutagenesis plus in vivo validation, single lab with multiple orthogonal methods","pmids":["42168988"],"is_preprint":false},{"year":2024,"finding":"RTL8, a related Mart-family gene whose protein shares homology with the N-terminal gag-like capsid domain of PEG10, is incorporated into PEG10-derived virus-like particles (VLPs) and inhibits PEG10 VLP formation or release by binding to the N-terminal domain of PEG10 capsid, decreasing VLP abundance and increasing intracellular PEG10.","method":"VLP purification by iodixanol ultracentrifugation, Co-IP of RTL8 with PEG10, RTL8 overexpression/knockdown with VLP quantification","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple biochemical and cell biology methods (VLP purification, Co-IP, gain/loss of function), single lab","pmids":["39775359"],"is_preprint":false},{"year":2023,"finding":"PEG10 knockdown in trophoblast stem cells (hTSCs) reduces activation of the canonical TGF-β signaling effector SMAD binding element (luciferase assay), indicating that PEG10 positively regulates canonical TGF-β signaling in trophoblasts.","method":"siRNA knockdown of PEG10 in hTSCs, SMAD binding element luciferase reporter assay","journal":"Reproductive biology and endocrinology","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single reporter assay in a single study, limited mechanistic follow-up","pmids":["37464405"],"is_preprint":false},{"year":2015,"finding":"The AR and the E2F/RB pathway dynamically regulate distinct post-transcriptional and post-translational isoforms of PEG10 at distinct stages of neuroendocrine prostate cancer development; PEG10 promotes G0/G1 cell-cycle progression in the context of TP53 loss and regulates Snail expression via TGF-β signaling to promote invasion.","method":"Patient-derived xenograft model of NEPC, siRNA knockdown, cell cycle analysis, invasion assay","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — patient-derived xenograft plus multiple in vitro functional assays, single lab","pmids":["26235627"],"is_preprint":false},{"year":2021,"finding":"Menin displaces the menin-MLL1 complex from the PEG10 promoter upon pharmacological inhibition, reducing H3K4 methylation and causing transcriptional repression of PEG10 (replicated finding, corroborating the Kempinska 2017 paper).","method":"ChIP assay, MI-503 inhibitor treatment","journal":"Acta pharmacologica Sinica","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single ChIP experiment in a study primarily about CTR9, supporting but not extending the Kempinska 2017 finding","pmids":["34876700"],"is_preprint":false},{"year":2025,"finding":"PEG10-ORF1 (Gag-like protein) plays an essential and distinct role in labyrinth trophoblast precursor (LaTP) cell development and mid-to-late gestational labyrinthine microarchitecture; mice retaining only the ORF1/2 fusion but lacking ORF1 protein show placental labyrinth underdevelopment and growth retardation, distinguishing the roles of the two PEG10 protein products.","method":"Genetic mouse model with selective ablation of ORF1 while preserving ORF1/2 protein, histological placental analysis, cell lineage analysis","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo genetic dissection of two protein products with defined phenotype; preprint, not yet peer-reviewed","pmids":["bio_10.1101_2025.10.08.681076"],"is_preprint":true},{"year":2024,"finding":"PEG10, as a core component of stress granules, drives recruitment of UBQLN2 to stress granules (requires RTL8 co-expression), remodels kinetics of stress granule disassembly, and alters stress granule composition by incorporating extracellular vesicle proteins. Within stress granules, PEG10 forms virus-like particles.","method":"Stress granule imaging, UBQLN2 co-localization, VLP detection within condensates, RTL8 knockdown/overexpression","journal":"bioRxiv","confidence":"Low","confidence_rationale":"Tier 3 / Weak — preprint, imaging and biochemical assays, no independent replication yet","pmids":["bio_10.1101_2024.10.24.620053"],"is_preprint":true},{"year":2026,"finding":"PEG10 overexpression in neurons selectively binds U/G-rich RNAs and causes widespread mRNA splicing changes, including an exon-skipping event in neuregulin 3 (NRG3), reducing NRG3 protein levels along cellular processes and impairing NRG3/ERBB4 signaling. These splicing changes partially overlap with changes seen in UBQLN2-associated and sporadic ALS patient samples.","method":"RNA-seq after PEG10 overexpression, RNA-binding selectivity assay, immunofluorescence for NRG3, comparison with ALS patient data","journal":"bioRxiv","confidence":"Low","confidence_rationale":"Tier 3 / Weak — preprint, single lab, mechanistic findings not yet peer-reviewed","pmids":["42239172"],"is_preprint":true}],"current_model":"PEG10 is a domesticated Ty3/gypsy LTR retrotransposon-derived gene encoding two proteins via −1 programmed frameshifting: a Gag-like ORF1 protein and a Gag-Pol-like ORF1/2 fusion protein containing an active aspartic protease domain; ORF1 is essential for early placental labyrinth development while the ORF1/2 protease domain maintains fetal capillary integrity in late gestation. PEG10 forms virus-like particles that preferentially package its own mRNA via 3′ UTR recognition and release it in extracellular vesicles. Its stability is regulated post-translationally by a UBQLN2/UBE3A-dependent ubiquitin-proteasome pathway (targeting gag-pol but not gag), deubiquitination by USP9X, and differential ubiquitination by SIAH1 (degradative) versus SIAH2 (stabilizing). PEG10 is transcriptionally activated by c-MYC, E2F-1/E2F-4, and the menin-MLL1 complex, and repressed by activated AR. Through its Gag domain, PEG10 sequesters apoptotic regulator SIAH1, inhibits TGF-β/BMP-SMAD signaling, participates in stress granule biology, and in neurons modulates mRNA splicing including of NRG3."},"narrative":{"mechanistic_narrative":"PEG10 is a domesticated Ty3/gypsy LTR retrotransposon-derived gene whose Gag- and Pol-homologous open reading frames encode proteins essential for mammalian placental development [PMID:11318613, PMID:16341224]. Translation produces two products via >60% efficient programmed −1 frameshifting: an ORF1 (Gag-like) protein and an ORF1/2 (Gag-Pol-like) fusion bearing an active aspartic protease (Asp-Ser-Gly active-site motif) that processes the fusion protein [PMID:17942406]. In vivo these products have separable developmental roles — the ORF1/2 protease motif maintains fetal capillary integrity in mid-to-late gestation, with active-site knock-in mutation causing perinatal lethality and placental vascular defects [PMID:34559199]. Structurally, a stably folded PEG10 domain matches the C-terminal capsid (CA) domain of retrotransposon Gag proteins [PMID:34357660], and the Gag domain drives vesicle budding and assembles virus-like particles that preferentially package PEG10's own mRNA through 3′ UTR sequences, enabling reprogrammable RNA delivery [PMID:30951545, PMID:34413232]. PEG10 binds cellular RNAs, localizes to stress granules, associates with the ataxia proteins ATXN2 and ATXN10, and is secreted in extracellular vesicles [PMID:34467244]. PEG10 protein abundance is tightly controlled post-translationally: the ORF1/2 (gag-pol) form is selectively degraded through a UBQLN2/UBE3A-dependent ubiquitin-proteasome pathway requiring specific pol-region lysines [PMID:41234208, PMID:36951542], deubiquitinated and stabilized by USP9X [PMID:38677662], and differentially ubiquitinated by SIAH1 (degradative, tumor-suppressive) versus SIAH2 (stabilizing, tumor-promoting) at distinct lysine residues in its PAIR domain [PMID:42168988]. Transcriptionally, PEG10 is a direct target activated by c-MYC, E2F-1/E2F-4, and the menin-MLL1/H3K4-methylation complex, and repressed by activated androgen receptor [PMID:16423995, PMID:18625225, PMID:29142068, PMID:31013476]. Functionally, PEG10 inhibits TGF-β/BMP-SMAD signaling and promotes proliferation, EMT, invasion, and apoptotic resistance across multiple cancers [PMID:29044189, PMID:28004118, PMID:33391523], and its loss accumulates in UBE3A-deficient (Angelman syndrome) neurons where it perturbs neuronal migration [PMID:34467244].","teleology":[{"year":2001,"claim":"Established that PEG10 is not a conventional cellular gene but a domesticated retroelement, framing all later mechanistic interpretation of its Gag/Pol-derived activities.","evidence":"Sequence and genomic analysis of two overlapping ORFs homologous to Ty3/gypsy Gag and Pol","pmids":["11318613"],"confidence":"Medium","gaps":["Did not demonstrate protein expression or any biochemical activity","Frameshifting and protease activity were inferred, not shown"]},{"year":2003,"claim":"First functional role assigned to PEG10 — physical sequestration of the apoptotic mediator SIAH1 — linking the Gag protein to cell survival.","evidence":"Co-immunoprecipitation and overexpression apoptosis rescue assay","pmids":["12810624"],"confidence":"Medium","gaps":["Single Co-IP, single lab","Binding domain on PEG10 not mapped at this stage"]},{"year":2005,"claim":"Genetic proof that PEG10 is indispensable for mammalian development, showing the domesticated retroelement was co-opted for placentation.","evidence":"Peg10 knockout mice with embryonic lethality and absent spongiotrophoblast/labyrinth layers","pmids":["16341224"],"confidence":"High","gaps":["Did not distinguish which protein product or activity drives the phenotype","Molecular mechanism in trophoblast not defined"]},{"year":2006,"claim":"Identified the first direct upstream transcriptional activator, connecting PEG10 to oncogenic MYC signaling.","evidence":"ChIP, MYC RNAi, and E-box site-directed mutagenesis at the PEG10 first intron","pmids":["16423995"],"confidence":"High","gaps":["Downstream consequences of MYC-driven PEG10 not established here"]},{"year":2007,"claim":"Demonstrated the predicted retroviral translational and enzymatic mechanisms are real in vivo: efficient −1 frameshifting and a catalytically active aspartic protease that processes the fusion protein.","evidence":"In vivo frameshift reporter assay plus active-site (Asp-Ser-Gly) mutagenesis in mouse/human placenta","pmids":["17942406"],"confidence":"High","gaps":["Substrates of the protease beyond autoprocessing not identified","Developmental requirement of the protease not yet tested in vivo"]},{"year":2007,"claim":"Extended PEG10 regulation to androgen signaling and broadened its functional reach beyond placenta to adipogenesis and hepatocarcinogenesis.","evidence":"AR ChIP, AR/PEG10 siRNA, xenografts (HCC); separate RNAi in 3T3-L1 adipocyte differentiation","pmids":["17369855","17707377"],"confidence":"High","gaps":["Mechanism by which PEG10 protein executes proliferation/anti-apoptosis not defined","Adipogenesis link relies on a single RNAi study"]},{"year":2008,"claim":"Placed PEG10 within the E2F/RB transcriptional network controlling proliferation and apoptosis.","evidence":"ChIP for E2F-1/E2F-4 at the promoter with apoptosis assays","pmids":["18625225"],"confidence":"Medium","gaps":["Functional output of E2F-driven PEG10 described only phenomenologically"]},{"year":2010,"claim":"Revealed additional translational complexity through a non-AUG upstream start codon, indicating multiple PEG10 protein isoforms.","evidence":"Mutational analysis of translation start sites with reporter constructs","pmids":["20084274"],"confidence":"Medium","gaps":["Functional distinction of non-AUG vs AUG products not established","Not independently replicated"]},{"year":2016,"claim":"Connected PEG10 to TGF-β-driven EMT and chemoresistance, and uncovered miRNA-level control of PEG10 protein output.","evidence":"shRNA/overexpression with TGF-β1 stimulation (HCC EMT); miR-122 3′UTR reporter and knockout mouse","pmids":["28004118","27370270"],"confidence":"Medium","gaps":["Direction of PEG10–TGF-β relationship appears context-dependent across studies","Molecular mechanism of PEG10 action on EMT effectors unclear"]},{"year":2017,"claim":"Defined PEG10 as a repressor of both TGF-β and BMP SMAD branches in a mutually inhibitory loop and added epigenetic (menin-MLL1/H3K4me) and E2F-1/cell-cycle regulatory layers.","evidence":"SMAD reporter assays, siRNA, phospho-SMAD blots (chondrosarcoma); menin-MLL1 ChIP with MI-503 (HCC); E2F-1 ChIP with cell-cycle/invasion assays (pancreatic)","pmids":["29044189","29142068","28193232"],"confidence":"Medium","gaps":["Whether PEG10 represses SMAD signaling directly or via a partner unresolved","Opposing TGF-β reports across tissues not reconciled"]},{"year":2018,"claim":"Mechanistically linked PEG10's TGF-β/BMP antagonism to specific kinase cascades and identified TSG101 as a protein-level stabilizer.","evidence":"AKT/p38 inhibitor rescue and MMP analysis (chondrosarcoma); TSG101 Co-IP and degradation assays","pmids":["30094509","30450735"],"confidence":"Medium","gaps":["TSG101 stabilization mechanism (direct vs proteasome-shielding) not fully defined","Kinase-pathway link is correlative through inhibitor rescue"]},{"year":2019,"claim":"Demonstrated the Gag domain retains capsid-like vesicle-budding and RNA-binding activity, tying these directly to trophoblast differentiation, and identified USP9X as a deubiquitinating regulator.","evidence":"Vesicle budding assay, RNA-IP, PEG10-deficient trophoblast stem cell differentiation, USP9X Co-IP","pmids":["30951545"],"confidence":"Medium","gaps":["RNA cargo selectivity mechanism not yet defined","USP9X functional consequence on PEG10 levels not quantified here"]},{"year":2020,"claim":"Showed gag-pol self-cleavage liberates a nucleus-targeted nucleocapsid fragment affecting axon-remodeling genes and identified UBQLN2 as a regulator, opening the neurodegeneration axis.","evidence":"Protein fractionation, nuclear imaging, expression profiling, UBQLN2 perturbation in cells and spinal cord; plus D370A protease mutagenesis in proliferation assays","pmids":["36951542","32244497"],"confidence":"Medium","gaps":["Nuclear fragment's direct gene targets unmapped","Protease's role in viability is bidirectional and incompletely explained"]},{"year":2021,"claim":"Crystallography confirmed capsid homology and biochemistry established self-mRNA encapsidation, while disease-context studies tied PEG10 to UBE3A/Angelman neurons, stress granules, and an IGF2BP1/m6A stabilization-to-cell-cycle axis.","evidence":"X-ray structure vs Gag CA; VLP purification, RNA-seq, UTR-swap delivery; proteomics with UBE3A ASO and ATXN2/10 Co-IP; RIP-seq/m6A/p16-p18 promoter binding","pmids":["34357660","34413232","34467244","33391523"],"confidence":"High","gaps":["How nuclear PEG10 binds p16/p18 promoters mechanistically unclear","Stress-granule and EV roles not yet integrated with placental function"]},{"year":2021,"claim":"Genetically separated the two protein products in vivo, showing the ORF1/2 protease motif specifically maintains fetal capillary architecture, and added AR-repression/neuroendocrine and CTCL oncogenic contexts.","evidence":"Protease active-site knock-in mice with vascular histology; AR enhancer ChIP in NEPC; 7q21.3 amplification and PEG10/KLF2/NF-κB axis in CTCL","pmids":["34559199","31013476","34582557"],"confidence":"High","gaps":["Protease substrate in fetal capillary maintenance not identified","ORF1-specific developmental role not yet dissected at this point"]},{"year":2023,"claim":"Resolved the selectivity of PEG10 turnover: only the gag-pol fusion is degraded via UBQLN2/UBE3A-dependent, lysine-specific ubiquitination, distinguishing it from the stable gag protein.","evidence":"Co-IP, ubiquitination assays, pol-region lysine mutagenesis, proteasome inhibition, UBE3A siRNA","pmids":["41234208"],"confidence":"High","gaps":["Why gag escapes degradation despite UBQLN2 binding not fully explained","Physiological tissue where this control dominates not defined"]},{"year":2024,"claim":"Identified opposing capsid-domain partners and a stabilizing deubiquitinase, refining how PEG10 VLP formation and protein levels are tuned.","evidence":"RTL8 VLP incorporation/Co-IP and VLP quantification; USP9X Co-IP, ubiquitination assay, and in vivo CTCL model","pmids":["39775359","38677662"],"confidence":"Medium","gaps":["Physiological role of RTL8 inhibition of VLPs unknown","USP9X mechanism studied only in CTCL"]},{"year":2026,"claim":"Established that SIAH1 and SIAH2 ubiquitinate the same PAIR domain at distinct lysines to produce opposite fates, providing a molecular basis for PEG10's bidirectional role in HCC.","evidence":"Co-IP, ubiquitination assays with site-specific lysine mutagenesis, xenografts, clinical correlation","pmids":["42168988"],"confidence":"High","gaps":["How K48 vs K63 linkages at shared/distinct lysines yield opposite stability not mechanistically resolved","Interplay with UBQLN2/USP9X pathways untested"]},{"year":null,"claim":"How PEG10's distinct activities — placental morphogenesis, capsid/RNA encapsidation, stress-granule/EV biology, neuronal splicing, and oncogenic signaling — are partitioned between its ORF1 and ORF1/2 products and coordinated in vivo remains unresolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["Substrate repertoire of the aspartic protease unidentified","Direct nuclear/promoter targets of liberated PEG10 fragments unmapped","Neuronal splicing role (NRG3) and stress-granule functions rest on preprints awaiting peer review"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[9,10,11,35]},{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[2,12,15]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[22]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[3,18]},{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[14,10]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[13,22]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[11,34]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[9,10,11]}],"pathway":[{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[0,12,33]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[27,28,26]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[18,19,17]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[7,22,31]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[4,6,16,21]},{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[9,10]}],"complexes":["virus-like particle","stress granule"],"partners":["SIAH1","SIAH2","UBQLN2","UBE3A","USP9X","TSG101","RTL8","ATXN2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q86TG7","full_name":"Retrotransposon-derived protein PEG10","aliases":["Embryonal carcinoma differentiation-regulated protein","Mammalian retrotransposon-derived protein 2","Myelin expression factor 3-like protein 1","MEF3-like protein 1","Paternally expressed gene 10 protein","Retrotransposon gag domain-containing protein 3","Retrotransposon-derived gag-like polyprotein","Ty3/Gypsy-like protein"],"length_aa":708,"mass_kda":80.2,"function":"Retrotransposon-derived protein that binds its own mRNA and self-assembles into virion-like capsids (PubMed:34413232). Forms virion-like extracellular vesicles that encapsulate their own mRNA and are released from cells, enabling intercellular transfer of PEG10 mRNA (PubMed:34413232). Binds its own mRNA in the 5'-UTR region, in the region near the boundary between the nucleocapsid (NC) and protease (PRO) coding sequences and in the beginning of the 3'-UTR region (PubMed:34413232). Involved in placenta formation: required for trophoblast stem cells differentiation (By similarity). Involved at the immediate early stage of adipocyte differentiation (By similarity). Overexpressed in many cancers and enhances tumor progression: promotes cell proliferation by driving cell cycle progression from G0/G1 (PubMed:12810624, PubMed:16423995, PubMed:26235627, PubMed:28193232). Enhances cancer progression by inhibiting the TGF-beta signaling, possibly via interaction with the TGF-beta receptor ACVRL1 (PubMed:15611116, PubMed:26235627, PubMed:30094509). May bind to the 5'-GCCTGTCTTT-3' DNA sequence of the MB1 domain in the myelin basic protein (MBP) promoter; additional evidences are however required to confirm this result (By similarity)","subcellular_location":"Extracellular vesicle membrane; Cytoplasm; Nucleus","url":"https://www.uniprot.org/uniprotkb/Q86TG7/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PEG10","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/PEG10","total_profiled":1310},"omim":[{"mim_id":"609810","title":"PATERNALLY EXPRESSED GENE 10; PEG10","url":"https://www.omim.org/entry/609810"},{"mim_id":"607794","title":"MEST INTRONIC TRANSCRIPT 1; MESTIT1","url":"https://www.omim.org/entry/607794"},{"mim_id":"607790","title":"TET METHYLCYTOSINE DIOXYGENASE 1; TET1","url":"https://www.omim.org/entry/607790"},{"mim_id":"601284","title":"ACTIVIN A RECEPTOR, TYPE II-LIKE 1; ACVRL1","url":"https://www.omim.org/entry/601284"},{"mim_id":"600030","title":"DISTAL-LESS HOMEOBOX 6; DLX6","url":"https://www.omim.org/entry/600030"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Cytosol","reliability":"Approved"},{"location":"Nucleoplasm","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"adrenal gland","ntpm":162.5},{"tissue":"placenta","ntpm":439.1}],"url":"https://www.proteinatlas.org/search/PEG10"},"hgnc":{"alias_symbol":["KIAA1051","HB-1","MEF3L","RGAG3","Mar2","Mart2","SIRH1","RTL2"],"prev_symbol":[]},"alphafold":{"accession":"Q86TG7","domains":[{"cath_id":"1.10.1200","chopping":"163-246","consensus_level":"medium","plddt":91.0433,"start":163,"end":246},{"cath_id":"2.40.70.10","chopping":"351-475","consensus_level":"high","plddt":82.3426,"start":351,"end":475},{"cath_id":"-","chopping":"553-603","consensus_level":"high","plddt":79.5606,"start":553,"end":603},{"cath_id":"1.20.5","chopping":"2-40","consensus_level":"medium","plddt":89.8208,"start":2,"end":40},{"cath_id":"1.10.1200","chopping":"91-160","consensus_level":"medium","plddt":86.8586,"start":91,"end":160}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q86TG7","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q86TG7-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q86TG7-F1-predicted_aligned_error_v6.png","plddt_mean":68.25},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PEG10","jax_strain_url":"https://www.jax.org/strain/search?query=PEG10"},"sequence":{"accession":"Q86TG7","fasta_url":"https://rest.uniprot.org/uniprotkb/Q86TG7.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q86TG7/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q86TG7"}},"corpus_meta":[{"pmid":"16341224","id":"PMC_16341224","title":"Deletion of Peg10, an imprinted gene acquired from a retrotransposon, causes early embryonic lethality.","date":"2005","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16341224","citation_count":351,"is_preprint":false},{"pmid":"34413232","id":"PMC_34413232","title":"Mammalian retrovirus-like protein PEG10 packages its own mRNA and can be pseudotyped for mRNA delivery.","date":"2021","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/34413232","citation_count":330,"is_preprint":false},{"pmid":"26235627","id":"PMC_26235627","title":"The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer.","date":"2015","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/26235627","citation_count":237,"is_preprint":false},{"pmid":"11318613","id":"PMC_11318613","title":"A retrotransposon-derived gene, PEG10, is a novel imprinted gene located on human chromosome 7q21.","date":"2001","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/11318613","citation_count":215,"is_preprint":false},{"pmid":"33391523","id":"PMC_33391523","title":"IGF2BP1 overexpression stabilizes PEG10 mRNA in an m6A-dependent manner and promotes endometrial cancer progression.","date":"2021","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/33391523","citation_count":175,"is_preprint":false},{"pmid":"12810624","id":"PMC_12810624","title":"Involvement of PEG10 in human hepatocellular carcinogenesis through interaction with SIAH1.","date":"2003","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/12810624","citation_count":143,"is_preprint":false},{"pmid":"17942406","id":"PMC_17942406","title":"Mammalian gene PEG10 expresses two reading frames by high efficiency -1 frameshifting in embryonic-associated tissues.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17942406","citation_count":96,"is_preprint":false},{"pmid":"16423995","id":"PMC_16423995","title":"PEG10 is a c-MYC target gene in cancer cells.","date":"2006","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/16423995","citation_count":86,"is_preprint":false},{"pmid":"12620933","id":"PMC_12620933","title":"Temporal regulation of the expression of syncytin (HERV-W), maternally imprinted PEG10, and SGCE in human placenta.","date":"2003","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/12620933","citation_count":72,"is_preprint":false},{"pmid":"30951545","id":"PMC_30951545","title":"The Gag protein PEG10 binds to RNA and regulates trophoblast stem cell lineage specification.","date":"2019","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/30951545","citation_count":62,"is_preprint":false},{"pmid":"14576465","id":"PMC_14576465","title":"Overexpression of a novel imprinted gene, PEG10, in human hepatocellular carcinoma and in regenerating mouse livers.","date":"2003","source":"Journal of biomedical science","url":"https://pubmed.ncbi.nlm.nih.gov/14576465","citation_count":62,"is_preprint":false},{"pmid":"30123090","id":"PMC_30123090","title":"PEG10 as an oncogene: expression regulatory mechanisms and role in tumor progression.","date":"2018","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/30123090","citation_count":60,"is_preprint":false},{"pmid":"17621626","id":"PMC_17621626","title":"Overexpression of the paternally expressed gene 10 (PEG10) from the imprinted locus on chromosome 7q21 in high-risk B-cell chronic lymphocytic leukemia.","date":"2007","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/17621626","citation_count":59,"is_preprint":false},{"pmid":"26934961","id":"PMC_26934961","title":"PEG10 promotes human breast cancer cell proliferation, migration and invasion.","date":"2016","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/26934961","citation_count":50,"is_preprint":false},{"pmid":"28193232","id":"PMC_28193232","title":"PEG10 overexpression induced by E2F-1 promotes cell proliferation, migration, and invasion in pancreatic cancer.","date":"2017","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/28193232","citation_count":50,"is_preprint":false},{"pmid":"25591808","id":"PMC_25591808","title":"Long noncoding RNA PEG10 regulates proliferation and invasion of esophageal cancer cells.","date":"2015","source":"Cancer gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/25591808","citation_count":50,"is_preprint":false},{"pmid":"34467244","id":"PMC_34467244","title":"Secreted retrovirus-like GAG-domain-containing protein PEG10 is regulated by UBE3A and is involved in Angelman syndrome pathophysiology.","date":"2021","source":"Cell reports. Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34467244","citation_count":45,"is_preprint":false},{"pmid":"29058812","id":"PMC_29058812","title":"The effects of Curcumin on HCT-116 cells proliferation and apoptosis via the miR-491/PEG10 pathway.","date":"2018","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29058812","citation_count":45,"is_preprint":false},{"pmid":"29142068","id":"PMC_29142068","title":"Pharmacologic Inhibition of the Menin-MLL Interaction Leads to Transcriptional Repression of PEG10 and Blocks Hepatocellular Carcinoma.","date":"2017","source":"Molecular cancer therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/29142068","citation_count":45,"is_preprint":false},{"pmid":"17126992","id":"PMC_17126992","title":"Identification of PEG10 as a progression related biomarker for hepatocellular carcinoma.","date":"2006","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/17126992","citation_count":44,"is_preprint":false},{"pmid":"16225771","id":"PMC_16225771","title":"PEG10 activation by co-stimulation of CXCR5 and CCR7 essentially contributes to resistance to apoptosis in CD19+CD34+ B cells from patients with B cell lineage acute and chronic lymphocytic leukemia.","date":"2004","source":"Cellular & molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/16225771","citation_count":44,"is_preprint":false},{"pmid":"20084274","id":"PMC_20084274","title":"Genetic and molecular analyses of PEG10 reveal new aspects of genomic organization, transcription and translation.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/20084274","citation_count":40,"is_preprint":false},{"pmid":"17369855","id":"PMC_17369855","title":"Androgen activates PEG10 to promote carcinogenesis in hepatic cancer cells.","date":"2007","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/17369855","citation_count":37,"is_preprint":false},{"pmid":"32826862","id":"PMC_32826862","title":"LncRNA SNAI3-AS1 promotes PEG10-mediated proliferation and metastasis via decoying of miR-27a-3p and miR-34a-5p in hepatocellular carcinoma.","date":"2020","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/32826862","citation_count":36,"is_preprint":false},{"pmid":"18625225","id":"PMC_18625225","title":"PEG10 directly regulated by E2Fs might have a role in the development of hepatocellular carcinoma.","date":"2008","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/18625225","citation_count":35,"is_preprint":false},{"pmid":"17707377","id":"PMC_17707377","title":"peg10, an imprinted gene, plays a crucial role in adipocyte differentiation.","date":"2007","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/17707377","citation_count":34,"is_preprint":false},{"pmid":"31013476","id":"PMC_31013476","title":"PEG10 is associated with treatment-induced neuroendocrine prostate cancer.","date":"2019","source":"Journal of molecular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/31013476","citation_count":33,"is_preprint":false},{"pmid":"34559199","id":"PMC_34559199","title":"PEG10 viral aspartic protease domain is essential for the maintenance of fetal capillary structure in the mouse placenta.","date":"2021","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/34559199","citation_count":33,"is_preprint":false},{"pmid":"29088808","id":"PMC_29088808","title":"The H19-PEG10/IGF2BP3 axis promotes gastric cancer progression in patients with high lymph node ratios.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/29088808","citation_count":32,"is_preprint":false},{"pmid":"36951542","id":"PMC_36951542","title":"UBQLN2 restrains the domesticated retrotransposon PEG10 to maintain neuronal health in ALS.","date":"2023","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/36951542","citation_count":30,"is_preprint":false},{"pmid":"36385135","id":"PMC_36385135","title":"LncRNA NALT1 promotes colorectal cancer progression via targeting PEG10 by sponging microRNA-574-5p.","date":"2022","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/36385135","citation_count":28,"is_preprint":false},{"pmid":"30953817","id":"PMC_30953817","title":"RETRACTED: lncRNA PEG10 promotes cell survival, invasion and migration by sponging miR-134 in human bladder cancer.","date":"2019","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/30953817","citation_count":28,"is_preprint":false},{"pmid":"30450735","id":"PMC_30450735","title":"TSG101 promotes the proliferation, migration and invasion of hepatocellular carcinoma cells by regulating the PEG10.","date":"2018","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30450735","citation_count":24,"is_preprint":false},{"pmid":"22673314","id":"PMC_22673314","title":"PEG10 promotes the migration of human Burkitt's lymphoma cells by up-regulating the expression of matrix metalloproteinase-2 and -9.","date":"2012","source":"Clinical and investigative medicine. Medecine clinique et experimentale","url":"https://pubmed.ncbi.nlm.nih.gov/22673314","citation_count":23,"is_preprint":false},{"pmid":"23807393","id":"PMC_23807393","title":"Regulation of murine placentogenesis by the retroviral genes Syncytin-A, Syncytin-B and Peg10.","date":"2013","source":"Differentiation; research in biological diversity","url":"https://pubmed.ncbi.nlm.nih.gov/23807393","citation_count":22,"is_preprint":false},{"pmid":"28928830","id":"PMC_28928830","title":"Overexpression of long noncoding RNA PEG10 promotes proliferation, invasion and metastasis of hypopharyngeal squamous cell carcinoma.","date":"2017","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/28928830","citation_count":21,"is_preprint":false},{"pmid":"20362226","id":"PMC_20362226","title":"PEG10 is a probable target for the amplification at 7q21 detected in hepatocellular carcinoma.","date":"2010","source":"Cancer genetics and cytogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/20362226","citation_count":21,"is_preprint":false},{"pmid":"34582557","id":"PMC_34582557","title":"PEG10 amplification at 7q21.3 potentiates large-cell transformation in cutaneous T-cell lymphoma.","date":"2022","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/34582557","citation_count":20,"is_preprint":false},{"pmid":"31389601","id":"PMC_31389601","title":"LncRNA PEG10 aggravates cardiac hypertrophy through regulating HOXA9.","date":"2019","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31389601","citation_count":19,"is_preprint":false},{"pmid":"28004118","id":"PMC_28004118","title":"PEG10 is imperative for TGF-β1-induced epithelial‑mesenchymal transition in hepatocellular carcinoma.","date":"2016","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/28004118","citation_count":19,"is_preprint":false},{"pmid":"26241757","id":"PMC_26241757","title":"Partial Loss of Genomic Imprinting Reveals Important Roles for Kcnq1 and Peg10 Imprinted Domains in Placental Development.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26241757","citation_count":19,"is_preprint":false},{"pmid":"32244497","id":"PMC_32244497","title":"Functional Study of the Retrotransposon-Derived Human PEG10 Protease.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32244497","citation_count":18,"is_preprint":false},{"pmid":"27370270","id":"PMC_27370270","title":"miR-122-mediated translational repression of PEG10 and its suppression in human hepatocellular carcinoma.","date":"2016","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/27370270","citation_count":18,"is_preprint":false},{"pmid":"37842090","id":"PMC_37842090","title":"Roles of retrovirus-derived PEG10 and PEG11/RTL1 in mammalian development and evolution and their involvement in human disease.","date":"2023","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/37842090","citation_count":17,"is_preprint":false},{"pmid":"33149023","id":"PMC_33149023","title":"Differential Expression of PEG10 Contributes to Aggressive Disease in Early Versus Late-Onset Colorectal Cancer.","date":"2020","source":"Diseases of the colon and rectum","url":"https://pubmed.ncbi.nlm.nih.gov/33149023","citation_count":17,"is_preprint":false},{"pmid":"29044189","id":"PMC_29044189","title":"TGF-β signalling and PEG10 are mutually exclusive and inhibitory in chondrosarcoma cells.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29044189","citation_count":16,"is_preprint":false},{"pmid":"32847979","id":"PMC_32847979","title":"Paternally Expressed Gene 10 (PEG10) Promotes Growth, Invasion, and Survival of Bladder Cancer.","date":"2020","source":"Molecular cancer therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/32847979","citation_count":15,"is_preprint":false},{"pmid":"31530569","id":"PMC_31530569","title":"PEG10 Promoter-Driven Expression of Reporter Genes Enables Molecular Imaging of Lethal Prostate Cancer.","date":"2019","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/31530569","citation_count":13,"is_preprint":false},{"pmid":"31241046","id":"PMC_31241046","title":"Knockdown long non-coding RNA PEG10 inhibits proliferation, migration and invasion of glioma cell line U251 by regulating miR-506.","date":"2019","source":"General physiology and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/31241046","citation_count":13,"is_preprint":false},{"pmid":"32976381","id":"PMC_32976381","title":"Long Non-Coding RNA Paternally Expressed Imprinted Gene 10 (PEG10) Elevates Diffuse Large B-Cell Lymphoma Progression by Regulating Kinesin Family Member 2A (KIF2A) via Targeting MiR-101-3p.","date":"2020","source":"Medical science monitor : international medical journal of experimental and clinical research","url":"https://pubmed.ncbi.nlm.nih.gov/32976381","citation_count":13,"is_preprint":false},{"pmid":"34633608","id":"PMC_34633608","title":"Circ_0075804 promotes the malignant behaviors of retinoblastoma cells by binding to miR-138-5p to induce PEG10 expression.","date":"2021","source":"International ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/34633608","citation_count":13,"is_preprint":false},{"pmid":"34934172","id":"PMC_34934172","title":"Folate deficiency disturbs PEG10 methylation modifications in human spina bifida.","date":"2021","source":"Pediatric research","url":"https://pubmed.ncbi.nlm.nih.gov/34934172","citation_count":12,"is_preprint":false},{"pmid":"30094509","id":"PMC_30094509","title":"PEG10 counteracts signaling pathways of TGF-β and BMP to regulate growth, motility and invasion of SW1353 chondrosarcoma cells.","date":"2018","source":"Journal of bone and mineral metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/30094509","citation_count":12,"is_preprint":false},{"pmid":"22137777","id":"PMC_22137777","title":"Elevated expression of PEG10 in human placentas from preeclamptic pregnancies.","date":"2011","source":"Acta histochemica","url":"https://pubmed.ncbi.nlm.nih.gov/22137777","citation_count":12,"is_preprint":false},{"pmid":"34876700","id":"PMC_34876700","title":"Transcriptional regulator CTR9 promotes hepatocellular carcinoma progression and metastasis via increasing PEG10 transcriptional activity.","date":"2021","source":"Acta pharmacologica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/34876700","citation_count":12,"is_preprint":false},{"pmid":"29940767","id":"PMC_29940767","title":"Knockdown of long non-coding RNA PEG10 inhibits growth, migration and invasion of gastric carcinoma cells via up-regulating miR-3200.","date":"2018","source":"Neoplasma","url":"https://pubmed.ncbi.nlm.nih.gov/29940767","citation_count":12,"is_preprint":false},{"pmid":"17660697","id":"PMC_17660697","title":"Imprinting analyses of the porcine GATM and PEG10 genes in placentas on days 75 and 90 of gestation.","date":"2007","source":"Genes & genetic systems","url":"https://pubmed.ncbi.nlm.nih.gov/17660697","citation_count":12,"is_preprint":false},{"pmid":"38017459","id":"PMC_38017459","title":"Targeting PEG10 as a novel therapeutic approach to overcome CDK4/6 inhibitor resistance in breast cancer.","date":"2023","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/38017459","citation_count":11,"is_preprint":false},{"pmid":"26447468","id":"PMC_26447468","title":"HIV-1 and Human PEG10 Frameshift Elements Are Functionally Distinct and Distinguished by Novel Small Molecule Modulators.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26447468","citation_count":11,"is_preprint":false},{"pmid":"32878957","id":"PMC_32878957","title":"The Landscape of Genomic Imprinting at the Porcine SGCE/PEG10 Locus from Methylome and Transcriptome of Parthenogenetic Embryos.","date":"2020","source":"G3 (Bethesda, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/32878957","citation_count":11,"is_preprint":false},{"pmid":"30941768","id":"PMC_30941768","title":"Long noncoding RNA PEG10 facilitates bladder cancer cells proliferation, migration, and invasion via repressing microRNA-29b.","date":"2019","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/30941768","citation_count":10,"is_preprint":false},{"pmid":"35212607","id":"PMC_35212607","title":"Silencing of long chain noncoding RNA paternally expressed gene (PEG10) inhibits the progression of neuroblastoma by regulating microRNA-449a (miR-449a)/ribosomal protein S2 (RPS2) axis.","date":"2022","source":"Bioengineered","url":"https://pubmed.ncbi.nlm.nih.gov/35212607","citation_count":9,"is_preprint":false},{"pmid":"37464405","id":"PMC_37464405","title":"Paternal Expressed Gene 10 (PEG10) is decreased in early-onset preeclampsia.","date":"2023","source":"Reproductive biology and endocrinology : RB&E","url":"https://pubmed.ncbi.nlm.nih.gov/37464405","citation_count":7,"is_preprint":false},{"pmid":"34357660","id":"PMC_34357660","title":"Structural evidence that MOAP1 and PEG10 are derived from retrovirus/retrotransposon Gag proteins.","date":"2021","source":"Proteins","url":"https://pubmed.ncbi.nlm.nih.gov/34357660","citation_count":7,"is_preprint":false},{"pmid":"25526181","id":"PMC_25526181","title":"Expression and significance of the imprinted gene PEG10 in placenta of patients with preeclampsia.","date":"2014","source":"Genetics and molecular research : GMR","url":"https://pubmed.ncbi.nlm.nih.gov/25526181","citation_count":7,"is_preprint":false},{"pmid":"37932427","id":"PMC_37932427","title":"GPC3 and PEG10 peptides associated with placental gp96 elicit specific T cell immunity against hepatocellular carcinoma.","date":"2023","source":"Cancer immunology, immunotherapy : CII","url":"https://pubmed.ncbi.nlm.nih.gov/37932427","citation_count":7,"is_preprint":false},{"pmid":"2199314","id":"PMC_2199314","title":"Extragenic suppressors of mar2(sir3) mutations in Saccharomyces cerevisiae.","date":"1990","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/2199314","citation_count":7,"is_preprint":false},{"pmid":"35714554","id":"PMC_35714554","title":"Influences of fresh and frozen embryo transfer on neonatal birthweight and the expression of imprinted genes PEG10 /L3MBTL1 in placenta.","date":"2022","source":"Reproductive biology","url":"https://pubmed.ncbi.nlm.nih.gov/35714554","citation_count":7,"is_preprint":false},{"pmid":"21113679","id":"PMC_21113679","title":"Molecular and DNA methylation analysis of Peg10 and Xist gene in sheep.","date":"2010","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/21113679","citation_count":6,"is_preprint":false},{"pmid":"33515207","id":"PMC_33515207","title":"Expression and DNA Methylation Status of the Imprinted Genes PEG10 and L3MBTL1 in the Umbilical Cord Blood and Placenta of the Offspring of Assisted Reproductive Technology.","date":"2021","source":"Reproductive sciences (Thousand Oaks, Calif.)","url":"https://pubmed.ncbi.nlm.nih.gov/33515207","citation_count":6,"is_preprint":false},{"pmid":"39775359","id":"PMC_39775359","title":"The gag-like gene RTL8 antagonizes PEG10-mediated virus like particles.","date":"2024","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/39775359","citation_count":5,"is_preprint":false},{"pmid":"18550496","id":"PMC_18550496","title":"[Genetic imprinted gene PEG10 expression in deciduas from inevitable abortion].","date":"2008","source":"Yi chuan = Hereditas","url":"https://pubmed.ncbi.nlm.nih.gov/18550496","citation_count":4,"is_preprint":false},{"pmid":"40183369","id":"PMC_40183369","title":"Roles of PEG10 in cancer and neurodegenerative disorder (Review).","date":"2025","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/40183369","citation_count":3,"is_preprint":false},{"pmid":"35739280","id":"PMC_35739280","title":"CRISPR activation screen identifies TGFβ-associated PEG10 as a crucial tumor suppressor in Ewing sarcoma.","date":"2022","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/35739280","citation_count":3,"is_preprint":false},{"pmid":"38677662","id":"PMC_38677662","title":"Abrogation of USP9X Is a Potential Strategy to Decrease PEG10 Levels and Impede Tumor Progression in Cutaneous T-Cell Lymphoma.","date":"2024","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/38677662","citation_count":3,"is_preprint":false},{"pmid":"20345586","id":"PMC_20345586","title":"Biallele expression of PEG10 gene in primordial germ cells derived from day 27 porcine fetuses.","date":"2010","source":"Reproduction in domestic animals = Zuchthygiene","url":"https://pubmed.ncbi.nlm.nih.gov/20345586","citation_count":3,"is_preprint":false},{"pmid":"21586401","id":"PMC_21586401","title":"[The methylation status of PEG10 in placentas of cloned transgenic calves].","date":"2011","source":"Yi chuan = Hereditas","url":"https://pubmed.ncbi.nlm.nih.gov/21586401","citation_count":3,"is_preprint":false},{"pmid":"39579659","id":"PMC_39579659","title":"NAP1L5 promotes epithelial-mesenchymal transition by regulating PEG10 expression in acute myeloid leukaemia.","date":"2024","source":"Leukemia research","url":"https://pubmed.ncbi.nlm.nih.gov/39579659","citation_count":2,"is_preprint":false},{"pmid":"20460050","id":"PMC_20460050","title":"[MiR-122 regulates the expression of PEG10 in hepatoma cell lines].","date":"2010","source":"Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/20460050","citation_count":2,"is_preprint":false},{"pmid":"20037811","id":"PMC_20037811","title":"Suppressive effects of genomic imprinted gene PEG10 on hydrogen peroxide-induced apoptosis in L02 cells.","date":"2009","source":"Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban","url":"https://pubmed.ncbi.nlm.nih.gov/20037811","citation_count":2,"is_preprint":false},{"pmid":"40180104","id":"PMC_40180104","title":"Evolutionary dynamics of PEG10 and its interacting proteins during early and late-stage placental development in ruminants.","date":"2025","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/40180104","citation_count":1,"is_preprint":false},{"pmid":"41234208","id":"PMC_41234208","title":"UBQLN2 is necessary for UBE3A-mediated proteasomal degradation of the domesticated retroelement PEG10.","date":"2025","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/41234208","citation_count":1,"is_preprint":false},{"pmid":"19567027","id":"PMC_19567027","title":"[Establishment of PEG10 transgenic mouse and effects of PEG10 on growth, metastasis of transplanted tumor in mice].","date":"2009","source":"Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/19567027","citation_count":1,"is_preprint":false},{"pmid":"17456318","id":"PMC_17456318","title":"[Construction of recombinant plasmid human imprinted gene PEG10 and the primary functional identification in transfected cell lines].","date":"2007","source":"Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/17456318","citation_count":1,"is_preprint":false},{"pmid":"38594908","id":"PMC_38594908","title":"The landscape of allelic expression and DNA methylation at the bovine SGCE/PEG10 locus.","date":"2024","source":"Animal genetics","url":"https://pubmed.ncbi.nlm.nih.gov/38594908","citation_count":0,"is_preprint":false},{"pmid":"41594701","id":"PMC_41594701","title":"Placenta-Driven Evolution: Viral Gene Acquisition and PEG10's Essential Roles in Eutherian Placenta.","date":"2026","source":"Biomolecules","url":"https://pubmed.ncbi.nlm.nih.gov/41594701","citation_count":0,"is_preprint":false},{"pmid":"41429883","id":"PMC_41429883","title":"PEG10 loss of function causes Silver-Russell syndrome: a familial case with paternal deletion.","date":"2025","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/41429883","citation_count":0,"is_preprint":false},{"pmid":"39941098","id":"PMC_39941098","title":"Construction of a TAT-Cas9-EGFP Site-Specific Integration Eukaryotic Cell Line Using Efficient PEG10 Modification.","date":"2025","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/39941098","citation_count":0,"is_preprint":false},{"pmid":"41291383","id":"PMC_41291383","title":"Knockdown of FOXD3-AS1 inhibits the progression of prostate cancer by targeting miR-491-5p/PEG10.","date":"2025","source":"Journal of cancer research and clinical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/41291383","citation_count":0,"is_preprint":false},{"pmid":"42168988","id":"PMC_42168988","title":"Polyubiquitination and accumulation of PEG10 regulated by SIAH1/2 affiliates the progression of hepatocellular carcinoma.","date":"2026","source":"Cell communication and signaling : CCS","url":"https://pubmed.ncbi.nlm.nih.gov/42168988","citation_count":0,"is_preprint":false},{"pmid":"42205180","id":"PMC_42205180","title":"miR-379-5p promotes ovarian granulosa cell apoptosis in primary ovarian insufficiency by targeting KNDC1 and PEG10.","date":"2026","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/42205180","citation_count":0,"is_preprint":false},{"pmid":"42239172","id":"PMC_42239172","title":"The retroelement-derived human protein PEG10 is a regulator of mRNA splicing in neurons.","date":"2026","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/42239172","citation_count":0,"is_preprint":false},{"pmid":"21205473","id":"PMC_21205473","title":"[The imprinting status of genetic imprinted gene PEG10 in human hepatocellular carcinomas].","date":"2010","source":"Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/21205473","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.10.08.681076","title":"PEG10-ORF1 programs trophoblast progenitor development for placental labyrinth formation","date":"2025-10-09","source":"bioRxiv","url":"https://doi.org/10.1101/2025.10.08.681076","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.03.28.646022","title":"UBQLN2 facilitates degradation of the retrotransposon protein PEG10 via UBE3A activity","date":"2025-03-31","source":"bioRxiv","url":"https://doi.org/10.1101/2025.03.28.646022","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.10.24.620053","title":"Endogenous retrovirus-like proteins recruit UBQLN2 to stress granules and alter their functional properties","date":"2024-10-25","source":"bioRxiv","url":"https://doi.org/10.1101/2024.10.24.620053","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.05.24.655907","title":"The nucleus accumbens shell regulates hedonic feeding via a rostral hotspot","date":"2025-05-28","source":"bioRxiv","url":"https://doi.org/10.1101/2025.05.24.655907","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.11.17.24317299","title":"Associations between DNA methylation and cognitive function in early-stage hormone receptor-positive breast cancer patients","date":"2024-11-18","source":"bioRxiv","url":"https://doi.org/10.1101/2024.11.17.24317299","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.10.15.682441","title":"Interactome screening implicates BAG6 as a suppressor of UBQLN2 misfolding in ALS-dementia","date":"2025-10-15","source":"bioRxiv","url":"https://doi.org/10.1101/2025.10.15.682441","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":53534,"output_tokens":8597,"usd":0.144779,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":18144,"output_tokens":5867,"usd":0.118697,"stage2_stop_reason":"end_turn"},"total_usd":0.263476,"stage1_batch_id":"msgbatch_013a8chtv3AWyTqv4z4sEF4C","stage2_batch_id":"msgbatch_01AHsuW63vinsvuTgzmQ3n62","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2005,\n      \"finding\": \"Peg10 knockout mice exhibit early embryonic lethality due to severe placental defects, specifically absence of both the spongiotrophoblast and labyrinth layers, establishing PEG10 as essential for placental formation in mammals.\",\n      \"method\": \"Gene knockout in mice (loss-of-function) with histological phenotypic readout\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean KO with defined embryonic-lethal phenotype, independently referenced across many subsequent papers\",\n      \"pmids\": [\"16341224\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"PEG10 encodes two overlapping open reading frames (ORF1 and ORF2) with homology to the Gag and Pol proteins of Ty3/gypsy LTR retrotransposons, establishing it as a retrotransposon-derived domesticated gene.\",\n      \"method\": \"Sequence analysis of predicted ORFs, genomic localization\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Strong — sequence/bioinformatic identification replicated and validated by multiple subsequent functional studies\",\n      \"pmids\": [\"11318613\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"PEG10 undergoes programmed −1 frameshifting during translation with >60% efficiency in developing mouse placenta and amniotic membrane, producing both the ORF1 protein and an ORF1-2 fusion protein. Mutagenesis of the active-site motif (Asp-Ser-Gly) of the putative aspartic protease within ORF2 demonstrated that this enzyme is active and participates in post-translational processing of the ORF1-2 protein.\",\n      \"method\": \"In vivo frameshifting reporter assay, active-site mutagenesis, protein detection in mouse and human placenta\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vivo frameshift assay combined with active-site mutagenesis in a single rigorous study\",\n      \"pmids\": [\"17942406\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"PEG10 protein physically associates with SIAH1 (a mediator of apoptosis), and overexpression of PEG10 decreases SIAH1-mediated cell death, establishing PEG10 as an inhibitor of SIAH1-dependent apoptosis.\",\n      \"method\": \"Co-immunoprecipitation, overexpression with functional apoptosis assay\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — single Co-IP with functional rescue assay, single lab\",\n      \"pmids\": [\"12810624\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"c-MYC directly binds to an E-box-containing region in the PEG10 first intron and activates PEG10 transcription; site-directed mutagenesis of the most proximal E-box abolished promoter activity, placing PEG10 as a direct transcriptional target of MYC.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP), RNAi knockdown of MYC, site-directed mutagenesis of E-box\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — ChIP plus mutagenesis plus RNAi in a single study, direct mechanistic demonstration\",\n      \"pmids\": [\"16423995\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Androgen receptor (AR) directly binds to androgen-responsive elements in the promoter and exon 2 regions of the PEG10 gene in hepatoma cells (demonstrated by ChIP), and DHT-stimulated AR activates PEG10 expression to enhance HCC cell growth and apoptotic resistance and upregulate hTERT in a PEG10-dependent manner.\",\n      \"method\": \"ChIP assay, siRNA knockdown of AR and PEG10, AR transfection into AR-lacking cells, in vivo nude mouse xenograft\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP combined with genetic rescue experiments and in vivo model in a single study\",\n      \"pmids\": [\"17369855\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Transcription factors E2F-1 and E2F-4 directly bind to the PEG10 promoter and regulate its expression, as shown by ChIP; PEG10 is involved in repression of apoptosis induced by serum deprivation and chemotherapeutic drugs.\",\n      \"method\": \"ChIP, promoter binding assay, functional apoptosis assay\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP with functional follow-up, single lab\",\n      \"pmids\": [\"18625225\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"E2F-1 directly enhances PEG10 expression by binding to the PEG10 promoter (shown by ChIP), and PEG10 knockdown causes G0/G1 arrest mediated by p21 and p27 upregulation, and reduces pancreatic cancer cell invasion via the ERK/MMP7 pathway.\",\n      \"method\": \"ChIP assay, siRNA knockdown, cell cycle and invasion assays\",\n      \"journal\": \"Journal of experimental & clinical cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus multiple functional assays, single lab\",\n      \"pmids\": [\"28193232\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"PEG10 translation is initiated at a non-AUG start codon upstream of the previously predicted AUG codon as well as at the AUG codon, adding a new layer to its translational complexity.\",\n      \"method\": \"Molecular cloning and mutational analysis of translation start sites, promoter-reporter constructs\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — single lab with direct mutagenesis/reporter, no independent replication\",\n      \"pmids\": [\"20084274\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"The Gag domain of PEG10 promotes vesicle budding similar to HIV p24 Gag protein. PEG10 binds to numerous cellular RNAs including Hbegf mRNA, and loss of PEG10 in trophoblast stem cells reduces Hbegf expression and impairs differentiation into placental lineages. PEG10 was identified as a substrate of the deubiquitinating enzyme USP9X.\",\n      \"method\": \"Vesicle budding assay, RNA immunoprecipitation/proteomics (Verschueren et al.), PEG10-deficient TSC differentiation assay, Co-IP for USP9X interaction\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — multiple orthogonal methods (RNA-IP, vesicle assay, deubiquitinase substrate Co-IP, KO phenotype), single lab\",\n      \"pmids\": [\"30951545\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"PEG10 is a mammalian Gag homolog that preferentially binds and facilitates vesicular secretion of its own mRNA via sequences in its 3′ UTR. The mRNA cargo of PEG10 can be reprogrammed by flanking genes of interest with PEG10's untranslated regions, enabling selective endogenous encapsidation for cellular delivery (SEND).\",\n      \"method\": \"Biochemical purification of virus-like particles, RNA sequencing of particle contents, UTR-flanking reporter assays, functional delivery assays in mouse and human cells\",\n      \"journal\": \"Science (New York, N.Y.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal methods (particle purification, RNA-seq, UTR swap, delivery assays) in a rigorous study with functional validation\",\n      \"pmids\": [\"34413232\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"PEG10 protein increase (but not RNA) is dependent on UBE3A and proteasome function; UBE3A loss (as in Angelman syndrome neurons) leads to PEG10 protein accumulation. PEG10 binds to RNA and to ataxia-associated proteins ATXN2 and ATXN10, localizes to stress granules, and is secreted in extracellular vesicles where it modulates vesicle content. Overexpression of PEG10 during mouse brain development alters neuronal migration.\",\n      \"method\": \"Unbiased proteomics, antisense oligonucleotide modulation of UBE3A, Co-IP for ATXN2/ATXN10, stress granule localization imaging, extracellular vesicle purification, in vivo neuronal migration assay\",\n      \"journal\": \"Cell reports. Medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (proteomics, Co-IP, imaging, in vivo), disease model context with genetic rescue\",\n      \"pmids\": [\"34467244\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"The viral aspartic protease (DSG) motif in the POL-like region (ORF2) of PEG10 is essential for maintenance of fetal capillary structure in mid-to-late gestation placenta. Mice with a mutation in this motif show perinatal lethality with fetal vascular defects, specifically in the three trophoblast layers surrounding fetal capillary endothelial cells where PEG10 is expressed.\",\n      \"method\": \"Active-site knock-in mutagenesis in mice, histological analysis of placental vasculature, in situ expression localization\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vivo active-site mutagenesis with defined vascular phenotype and localization\",\n      \"pmids\": [\"34559199\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"The PEG10 gag-pol protein undergoes retrotransposon-like self-cleavage to generate a liberated 'nucleocapsid' fragment that uniquely localizes to the nucleus and alters expression of genes involved in axon remodeling. UBQLN2 regulates PEG10 gag-pol protein levels in human cells and spinal cord tissue.\",\n      \"method\": \"Protein fractionation, nuclear localization imaging, gene expression profiling, UBQLN2 knockdown/overexpression\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — subcellular fractionation with functional gene expression consequence, UBQLN2 regulation shown in cells and patient tissue\",\n      \"pmids\": [\"36951542\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"X-ray crystal structures of a stably folded domain of PEG10 reveal high structural similarity to the C-terminal capsid (CA) domain of cognate Gag proteins from LTR retrotransposons, confirming PEG10 as a domesticated Gag and suggesting possible preservation of capsid-assembly interactions.\",\n      \"method\": \"X-ray crystallography with structural comparison\",\n      \"journal\": \"Proteins\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structure with direct structural validation, single study\",\n      \"pmids\": [\"34357660\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"The aspartic protease domain of PEG10 ORF1/2 (containing the -Asp-Ser-Gly- active-site motif) is functionally active; overexpression of the ORF1/2 form increases cellular proliferation but also has a detrimental effect on cell viability, while an active-site D370A mutant alters these effects, indicating the protease domain modulates proliferation and viability.\",\n      \"method\": \"Active-site mutagenesis (D370A), cell transfection, proliferation and viability assays in HEK293T and HaCaT cells\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — active-site mutagenesis with functional cellular readout, single lab\",\n      \"pmids\": [\"32244497\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"The menin-MLL1 complex binds the PEG10 promoter and promotes H3K4 methylation to activate PEG10 transcription; pharmacological inhibition of the menin-MLL interaction with MI-503 displaces the complex from the PEG10 promoter, reduces H3K4 methylation, and transcriptionally represses PEG10 in HCC models.\",\n      \"method\": \"ChIP assay for menin-MLL1 at PEG10 promoter and H3K4me marks, small-molecule inhibitor treatment, in vivo xenograft\",\n      \"journal\": \"Molecular cancer therapeutics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP with pharmacological perturbation and in vivo confirmation, single lab\",\n      \"pmids\": [\"29142068\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"PEG10 is required for TGF-β1-induced epithelial-mesenchymal transition (EMT) in HCC cells; cells with PEG10 knocked down do not undergo EMT upon TGF-β1 stimulation and show reduced migration and invasion. Conversely, TGF-β1 upregulates PEG10 expression, and PEG10 overexpression confers chemoresistance.\",\n      \"method\": \"Adenoviral shRNA knockdown, overexpression, TGF-β1 stimulation, migration/invasion assays, EMT marker analysis\",\n      \"journal\": \"Oncology reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — multiple functional assays, genetic and pharmacological perturbation, single lab\",\n      \"pmids\": [\"28004118\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"PEG10 represses TGF-β and BMP-SMAD signaling pathways (both SMAD2/3 and SMAD1/5/9 branches) in chondrosarcoma cells; PEG10 knockdown increases phospho-SMAD3 and phospho-SMAD1/5/9, and reporter assays show PEG10 directly represses TGF-β and BMP signaling while TGF-β1 in turn suppresses PEG10 expression, establishing a mutually inhibitory relationship.\",\n      \"method\": \"Luciferase reporter assays for SMAD pathway activity, siRNA knockdown, immunoblotting for phospho-SMADs, microarray\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reporter assays combined with knockdown and signaling readouts, single lab\",\n      \"pmids\": [\"29044189\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"PEG10 knockdown in chondrosarcoma cells augments TGF-β1-induced motility via AKT phosphorylation (reversed by AKT inhibitor MK2206), and augments BMP-6-induced invasion via p38 MAPK and AKT pathways and upregulation of MMP-1, -3, and -13, identifying PEG10 as an inhibitor of TGF-β/BMP-driven motility and invasion through these kinase cascades.\",\n      \"method\": \"siRNA knockdown, AKT and p38 inhibitors, MMP inhibitors, invasion assays, immunoblotting\",\n      \"journal\": \"Journal of bone and mineral metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — pathway inhibitor rescue experiments combined with knockdown, multiple functional readouts, single lab\",\n      \"pmids\": [\"30094509\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"TSG101 physically interacts with PEG10 and protects it from proteasomal degradation; knockdown of TSG101 reduces PEG10 protein levels and downstream effectors p53, p21, and MMPs, while overexpression has opposite effects.\",\n      \"method\": \"Co-immunoprecipitation, iTRAQ proteomics, siRNA knockdown, overexpression, immunoblotting\",\n      \"journal\": \"Journal of cellular and molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — Co-IP plus proteomics plus functional knockdown, single lab\",\n      \"pmids\": [\"30450735\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Activated AR binds to the PEG10 enhancer (confirmed by ChIP assay) and represses PEG10 expression. Antagonism of AR increases PEG10 expression followed by increased neuroendocrine (NE) markers; androgen supplementation reverses this. PEG10 knockdown reduces NE markers and attenuates tumor growth in vitro and in vivo.\",\n      \"method\": \"ChIP assay, AR agonist/antagonist treatment, siRNA knockdown, in vivo xenograft\",\n      \"journal\": \"Journal of molecular endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP combined with pharmacological and genetic perturbation, in vivo validation, single lab\",\n      \"pmids\": [\"31013476\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"IGF2BP1 recognizes m6A sites in the 3′ UTR of PEG10 mRNA and recruits PABPC1 to enhance PEG10 mRNA stability, consequently increasing PEG10 protein expression; a large proportion of PEG10 protein then binds p16 and p18 gene promoter sequences to repress their expression and accelerate the cell cycle.\",\n      \"method\": \"RNA-binding protein immunoprecipitation sequencing (RIP-seq), methylated RIP-seq, RNA-seq, Co-immunoprecipitation and mass spectrometry, xenograft\",\n      \"journal\": \"Theranostics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal omics and biochemical methods, single lab\",\n      \"pmids\": [\"33391523\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"miR-122 suppresses PEG10 protein expression via direct binding to the 3′ UTR of the PEG10 transcript (translational repression rather than mRNA degradation), demonstrated by reporter assay; deficiency of miR-122 in knockout mice is associated with increased PEG10 and HCC progression.\",\n      \"method\": \"Luciferase reporter assay, miR-122 overexpression, miR-122 knockout mouse model, qRT-PCR and western blot\",\n      \"journal\": \"Journal of translational medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reporter assay with genetic validation in knockout mice, single lab\",\n      \"pmids\": [\"27370270\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"peg10 expression is induced early in adipocyte differentiation; peg10 RNAi inhibits 3T3-L1 differentiation into lipid-laden adipocytes, reduces C/EBPβ and C/EBPδ expression, and inhibits mitotic clonal expansion, establishing PEG10 as essential for adipogenesis at the immediate early stage.\",\n      \"method\": \"RNAi knockdown, adipocyte differentiation assay, gene expression analysis\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — RNAi with defined differentiation phenotype and downstream gene expression readout, single lab\",\n      \"pmids\": [\"17707377\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"PEG10 overexpression in cutaneous T-cell lymphoma increases cell size, promotes cell proliferation, and confers treatment resistance via a PEG10/KLF2/NF-κB signaling axis, driven by 7q21.3 amplification in large-cell transformation.\",\n      \"method\": \"Genomic hybridization, in vitro and in vivo models, pathway analysis (PEG10/KLF2/NF-κB), pharmacological targeting\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro and in vivo models with defined pathway, single lab\",\n      \"pmids\": [\"34582557\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"USP9X (a deubiquitinase) interacts with PEG10 and deubiquitinates it, thereby stabilizing PEG10 protein levels. Knockdown or pharmacological inhibition of USP9X leads to downregulation of PEG10 and its downstream pathway in CTCL, and impairs tumor growth in vivo.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, USP9X knockdown/inhibitor, in vivo tumor model\",\n      \"journal\": \"The Journal of investigative dermatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus ubiquitination assay plus in vivo model, single lab\",\n      \"pmids\": [\"38677662\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"UBQLN2 regulates proteasomal degradation of the PEG10 gag-pol protein specifically (not the gag protein). Both forms bind UBQLN2 independently of ubiquitination, but only gag-pol is degraded in a UBQLN2-, ubiquitin-, and proteasome-dependent fashion. Gag-pol ubiquitination is dependent on E3 ubiquitin ligase UBE3A, which requires UBQLN2 to regulate gag-pol levels; mutation of key lysine residues in the pol region renders gag-pol insensitive to UBQLN2.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, site-directed mutagenesis of lysine residues, proteasome inhibitor treatment, UBE3A siRNA knockdown\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal biochemical methods (Co-IP, ubiquitination assay, mutagenesis, genetic and pharmacological perturbation) establishing mechanism\",\n      \"pmids\": [\"41234208\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"SIAH1 and SIAH2 both bind to the PAIR domain of PEG10 and promote its polyubiquitination, but with opposing functional consequences: SIAH1 mediates K48-linked ubiquitination at Lys36 and K63-linked at Lys170, leading to decreased PEG10 levels and suppression of HCC; SIAH2 mediates K48-linked ubiquitination at Lys36 and K63-linked at Lys19 and Lys155, resulting in net accumulation of PEG10 and promotion of HCC.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assays, site-directed mutagenesis of lysine residues, xenograft models, clinical sample correlation\",\n      \"journal\": \"Cell communication and signaling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstitution of ubiquitination with site-specific mutagenesis plus in vivo validation, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"42168988\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"RTL8, a related Mart-family gene whose protein shares homology with the N-terminal gag-like capsid domain of PEG10, is incorporated into PEG10-derived virus-like particles (VLPs) and inhibits PEG10 VLP formation or release by binding to the N-terminal domain of PEG10 capsid, decreasing VLP abundance and increasing intracellular PEG10.\",\n      \"method\": \"VLP purification by iodixanol ultracentrifugation, Co-IP of RTL8 with PEG10, RTL8 overexpression/knockdown with VLP quantification\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple biochemical and cell biology methods (VLP purification, Co-IP, gain/loss of function), single lab\",\n      \"pmids\": [\"39775359\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"PEG10 knockdown in trophoblast stem cells (hTSCs) reduces activation of the canonical TGF-β signaling effector SMAD binding element (luciferase assay), indicating that PEG10 positively regulates canonical TGF-β signaling in trophoblasts.\",\n      \"method\": \"siRNA knockdown of PEG10 in hTSCs, SMAD binding element luciferase reporter assay\",\n      \"journal\": \"Reproductive biology and endocrinology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single reporter assay in a single study, limited mechanistic follow-up\",\n      \"pmids\": [\"37464405\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"The AR and the E2F/RB pathway dynamically regulate distinct post-transcriptional and post-translational isoforms of PEG10 at distinct stages of neuroendocrine prostate cancer development; PEG10 promotes G0/G1 cell-cycle progression in the context of TP53 loss and regulates Snail expression via TGF-β signaling to promote invasion.\",\n      \"method\": \"Patient-derived xenograft model of NEPC, siRNA knockdown, cell cycle analysis, invasion assay\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — patient-derived xenograft plus multiple in vitro functional assays, single lab\",\n      \"pmids\": [\"26235627\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Menin displaces the menin-MLL1 complex from the PEG10 promoter upon pharmacological inhibition, reducing H3K4 methylation and causing transcriptional repression of PEG10 (replicated finding, corroborating the Kempinska 2017 paper).\",\n      \"method\": \"ChIP assay, MI-503 inhibitor treatment\",\n      \"journal\": \"Acta pharmacologica Sinica\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single ChIP experiment in a study primarily about CTR9, supporting but not extending the Kempinska 2017 finding\",\n      \"pmids\": [\"34876700\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"PEG10-ORF1 (Gag-like protein) plays an essential and distinct role in labyrinth trophoblast precursor (LaTP) cell development and mid-to-late gestational labyrinthine microarchitecture; mice retaining only the ORF1/2 fusion but lacking ORF1 protein show placental labyrinth underdevelopment and growth retardation, distinguishing the roles of the two PEG10 protein products.\",\n      \"method\": \"Genetic mouse model with selective ablation of ORF1 while preserving ORF1/2 protein, histological placental analysis, cell lineage analysis\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo genetic dissection of two protein products with defined phenotype; preprint, not yet peer-reviewed\",\n      \"pmids\": [\"bio_10.1101_2025.10.08.681076\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"PEG10, as a core component of stress granules, drives recruitment of UBQLN2 to stress granules (requires RTL8 co-expression), remodels kinetics of stress granule disassembly, and alters stress granule composition by incorporating extracellular vesicle proteins. Within stress granules, PEG10 forms virus-like particles.\",\n      \"method\": \"Stress granule imaging, UBQLN2 co-localization, VLP detection within condensates, RTL8 knockdown/overexpression\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — preprint, imaging and biochemical assays, no independent replication yet\",\n      \"pmids\": [\"bio_10.1101_2024.10.24.620053\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"PEG10 overexpression in neurons selectively binds U/G-rich RNAs and causes widespread mRNA splicing changes, including an exon-skipping event in neuregulin 3 (NRG3), reducing NRG3 protein levels along cellular processes and impairing NRG3/ERBB4 signaling. These splicing changes partially overlap with changes seen in UBQLN2-associated and sporadic ALS patient samples.\",\n      \"method\": \"RNA-seq after PEG10 overexpression, RNA-binding selectivity assay, immunofluorescence for NRG3, comparison with ALS patient data\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — preprint, single lab, mechanistic findings not yet peer-reviewed\",\n      \"pmids\": [\"42239172\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"PEG10 is a domesticated Ty3/gypsy LTR retrotransposon-derived gene encoding two proteins via −1 programmed frameshifting: a Gag-like ORF1 protein and a Gag-Pol-like ORF1/2 fusion protein containing an active aspartic protease domain; ORF1 is essential for early placental labyrinth development while the ORF1/2 protease domain maintains fetal capillary integrity in late gestation. PEG10 forms virus-like particles that preferentially package its own mRNA via 3′ UTR recognition and release it in extracellular vesicles. Its stability is regulated post-translationally by a UBQLN2/UBE3A-dependent ubiquitin-proteasome pathway (targeting gag-pol but not gag), deubiquitination by USP9X, and differential ubiquitination by SIAH1 (degradative) versus SIAH2 (stabilizing). PEG10 is transcriptionally activated by c-MYC, E2F-1/E2F-4, and the menin-MLL1 complex, and repressed by activated AR. Through its Gag domain, PEG10 sequesters apoptotic regulator SIAH1, inhibits TGF-β/BMP-SMAD signaling, participates in stress granule biology, and in neurons modulates mRNA splicing including of NRG3.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"PEG10 is a domesticated Ty3/gypsy LTR retrotransposon-derived gene whose Gag- and Pol-homologous open reading frames encode proteins essential for mammalian placental development [#1, #0]. Translation produces two products via >60% efficient programmed −1 frameshifting: an ORF1 (Gag-like) protein and an ORF1/2 (Gag-Pol-like) fusion bearing an active aspartic protease (Asp-Ser-Gly active-site motif) that processes the fusion protein [#2]. In vivo these products have separable developmental roles — the ORF1/2 protease motif maintains fetal capillary integrity in mid-to-late gestation, with active-site knock-in mutation causing perinatal lethality and placental vascular defects [#12]. Structurally, a stably folded PEG10 domain matches the C-terminal capsid (CA) domain of retrotransposon Gag proteins [#14], and the Gag domain drives vesicle budding and assembles virus-like particles that preferentially package PEG10's own mRNA through 3′ UTR sequences, enabling reprogrammable RNA delivery [#9, #10]. PEG10 binds cellular RNAs, localizes to stress granules, associates with the ataxia proteins ATXN2 and ATXN10, and is secreted in extracellular vesicles [#11]. PEG10 protein abundance is tightly controlled post-translationally: the ORF1/2 (gag-pol) form is selectively degraded through a UBQLN2/UBE3A-dependent ubiquitin-proteasome pathway requiring specific pol-region lysines [#27, #13], deubiquitinated and stabilized by USP9X [#26], and differentially ubiquitinated by SIAH1 (degradative, tumor-suppressive) versus SIAH2 (stabilizing, tumor-promoting) at distinct lysine residues in its PAIR domain [#28]. Transcriptionally, PEG10 is a direct target activated by c-MYC, E2F-1/E2F-4, and the menin-MLL1/H3K4-methylation complex, and repressed by activated androgen receptor [#4, #6, #16, #21]. Functionally, PEG10 inhibits TGF-β/BMP-SMAD signaling and promotes proliferation, EMT, invasion, and apoptotic resistance across multiple cancers [#18, #17, #22], and its loss accumulates in UBE3A-deficient (Angelman syndrome) neurons where it perturbs neuronal migration [#11].\",\n  \"teleology\": [\n    {\n      \"year\": 2001,\n      \"claim\": \"Established that PEG10 is not a conventional cellular gene but a domesticated retroelement, framing all later mechanistic interpretation of its Gag/Pol-derived activities.\",\n      \"evidence\": \"Sequence and genomic analysis of two overlapping ORFs homologous to Ty3/gypsy Gag and Pol\",\n      \"pmids\": [\"11318613\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Did not demonstrate protein expression or any biochemical activity\", \"Frameshifting and protease activity were inferred, not shown\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"First functional role assigned to PEG10 — physical sequestration of the apoptotic mediator SIAH1 — linking the Gag protein to cell survival.\",\n      \"evidence\": \"Co-immunoprecipitation and overexpression apoptosis rescue assay\",\n      \"pmids\": [\"12810624\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single Co-IP, single lab\", \"Binding domain on PEG10 not mapped at this stage\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Genetic proof that PEG10 is indispensable for mammalian development, showing the domesticated retroelement was co-opted for placentation.\",\n      \"evidence\": \"Peg10 knockout mice with embryonic lethality and absent spongiotrophoblast/labyrinth layers\",\n      \"pmids\": [\"16341224\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not distinguish which protein product or activity drives the phenotype\", \"Molecular mechanism in trophoblast not defined\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Identified the first direct upstream transcriptional activator, connecting PEG10 to oncogenic MYC signaling.\",\n      \"evidence\": \"ChIP, MYC RNAi, and E-box site-directed mutagenesis at the PEG10 first intron\",\n      \"pmids\": [\"16423995\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream consequences of MYC-driven PEG10 not established here\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Demonstrated the predicted retroviral translational and enzymatic mechanisms are real in vivo: efficient −1 frameshifting and a catalytically active aspartic protease that processes the fusion protein.\",\n      \"evidence\": \"In vivo frameshift reporter assay plus active-site (Asp-Ser-Gly) mutagenesis in mouse/human placenta\",\n      \"pmids\": [\"17942406\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Substrates of the protease beyond autoprocessing not identified\", \"Developmental requirement of the protease not yet tested in vivo\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Extended PEG10 regulation to androgen signaling and broadened its functional reach beyond placenta to adipogenesis and hepatocarcinogenesis.\",\n      \"evidence\": \"AR ChIP, AR/PEG10 siRNA, xenografts (HCC); separate RNAi in 3T3-L1 adipocyte differentiation\",\n      \"pmids\": [\"17369855\", \"17707377\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which PEG10 protein executes proliferation/anti-apoptosis not defined\", \"Adipogenesis link relies on a single RNAi study\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Placed PEG10 within the E2F/RB transcriptional network controlling proliferation and apoptosis.\",\n      \"evidence\": \"ChIP for E2F-1/E2F-4 at the promoter with apoptosis assays\",\n      \"pmids\": [\"18625225\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional output of E2F-driven PEG10 described only phenomenologically\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Revealed additional translational complexity through a non-AUG upstream start codon, indicating multiple PEG10 protein isoforms.\",\n      \"evidence\": \"Mutational analysis of translation start sites with reporter constructs\",\n      \"pmids\": [\"20084274\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional distinction of non-AUG vs AUG products not established\", \"Not independently replicated\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Connected PEG10 to TGF-β-driven EMT and chemoresistance, and uncovered miRNA-level control of PEG10 protein output.\",\n      \"evidence\": \"shRNA/overexpression with TGF-β1 stimulation (HCC EMT); miR-122 3′UTR reporter and knockout mouse\",\n      \"pmids\": [\"28004118\", \"27370270\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direction of PEG10–TGF-β relationship appears context-dependent across studies\", \"Molecular mechanism of PEG10 action on EMT effectors unclear\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Defined PEG10 as a repressor of both TGF-β and BMP SMAD branches in a mutually inhibitory loop and added epigenetic (menin-MLL1/H3K4me) and E2F-1/cell-cycle regulatory layers.\",\n      \"evidence\": \"SMAD reporter assays, siRNA, phospho-SMAD blots (chondrosarcoma); menin-MLL1 ChIP with MI-503 (HCC); E2F-1 ChIP with cell-cycle/invasion assays (pancreatic)\",\n      \"pmids\": [\"29044189\", \"29142068\", \"28193232\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether PEG10 represses SMAD signaling directly or via a partner unresolved\", \"Opposing TGF-β reports across tissues not reconciled\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Mechanistically linked PEG10's TGF-β/BMP antagonism to specific kinase cascades and identified TSG101 as a protein-level stabilizer.\",\n      \"evidence\": \"AKT/p38 inhibitor rescue and MMP analysis (chondrosarcoma); TSG101 Co-IP and degradation assays\",\n      \"pmids\": [\"30094509\", \"30450735\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"TSG101 stabilization mechanism (direct vs proteasome-shielding) not fully defined\", \"Kinase-pathway link is correlative through inhibitor rescue\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Demonstrated the Gag domain retains capsid-like vesicle-budding and RNA-binding activity, tying these directly to trophoblast differentiation, and identified USP9X as a deubiquitinating regulator.\",\n      \"evidence\": \"Vesicle budding assay, RNA-IP, PEG10-deficient trophoblast stem cell differentiation, USP9X Co-IP\",\n      \"pmids\": [\"30951545\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"RNA cargo selectivity mechanism not yet defined\", \"USP9X functional consequence on PEG10 levels not quantified here\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Showed gag-pol self-cleavage liberates a nucleus-targeted nucleocapsid fragment affecting axon-remodeling genes and identified UBQLN2 as a regulator, opening the neurodegeneration axis.\",\n      \"evidence\": \"Protein fractionation, nuclear imaging, expression profiling, UBQLN2 perturbation in cells and spinal cord; plus D370A protease mutagenesis in proliferation assays\",\n      \"pmids\": [\"36951542\", \"32244497\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Nuclear fragment's direct gene targets unmapped\", \"Protease's role in viability is bidirectional and incompletely explained\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Crystallography confirmed capsid homology and biochemistry established self-mRNA encapsidation, while disease-context studies tied PEG10 to UBE3A/Angelman neurons, stress granules, and an IGF2BP1/m6A stabilization-to-cell-cycle axis.\",\n      \"evidence\": \"X-ray structure vs Gag CA; VLP purification, RNA-seq, UTR-swap delivery; proteomics with UBE3A ASO and ATXN2/10 Co-IP; RIP-seq/m6A/p16-p18 promoter binding\",\n      \"pmids\": [\"34357660\", \"34413232\", \"34467244\", \"33391523\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How nuclear PEG10 binds p16/p18 promoters mechanistically unclear\", \"Stress-granule and EV roles not yet integrated with placental function\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Genetically separated the two protein products in vivo, showing the ORF1/2 protease motif specifically maintains fetal capillary architecture, and added AR-repression/neuroendocrine and CTCL oncogenic contexts.\",\n      \"evidence\": \"Protease active-site knock-in mice with vascular histology; AR enhancer ChIP in NEPC; 7q21.3 amplification and PEG10/KLF2/NF-κB axis in CTCL\",\n      \"pmids\": [\"34559199\", \"31013476\", \"34582557\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Protease substrate in fetal capillary maintenance not identified\", \"ORF1-specific developmental role not yet dissected at this point\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Resolved the selectivity of PEG10 turnover: only the gag-pol fusion is degraded via UBQLN2/UBE3A-dependent, lysine-specific ubiquitination, distinguishing it from the stable gag protein.\",\n      \"evidence\": \"Co-IP, ubiquitination assays, pol-region lysine mutagenesis, proteasome inhibition, UBE3A siRNA\",\n      \"pmids\": [\"41234208\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Why gag escapes degradation despite UBQLN2 binding not fully explained\", \"Physiological tissue where this control dominates not defined\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Identified opposing capsid-domain partners and a stabilizing deubiquitinase, refining how PEG10 VLP formation and protein levels are tuned.\",\n      \"evidence\": \"RTL8 VLP incorporation/Co-IP and VLP quantification; USP9X Co-IP, ubiquitination assay, and in vivo CTCL model\",\n      \"pmids\": [\"39775359\", \"38677662\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Physiological role of RTL8 inhibition of VLPs unknown\", \"USP9X mechanism studied only in CTCL\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Established that SIAH1 and SIAH2 ubiquitinate the same PAIR domain at distinct lysines to produce opposite fates, providing a molecular basis for PEG10's bidirectional role in HCC.\",\n      \"evidence\": \"Co-IP, ubiquitination assays with site-specific lysine mutagenesis, xenografts, clinical correlation\",\n      \"pmids\": [\"42168988\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How K48 vs K63 linkages at shared/distinct lysines yield opposite stability not mechanistically resolved\", \"Interplay with UBQLN2/USP9X pathways untested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How PEG10's distinct activities — placental morphogenesis, capsid/RNA encapsidation, stress-granule/EV biology, neuronal splicing, and oncogenic signaling — are partitioned between its ORF1 and ORF1/2 products and coordinated in vivo remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Substrate repertoire of the aspartic protease unidentified\", \"Direct nuclear/promoter targets of liberated PEG10 fragments unmapped\", \"Neuronal splicing role (NRG3) and stress-granule functions rest on preprints awaiting peer review\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [9, 10, 11, 35]},\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [2, 12, 15]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [22]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [3, 18]},\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [14, 10]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [13, 22]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [11, 34]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [9, 10, 11]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [0, 12, 33]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [27, 28, 26]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [18, 19, 17]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [7, 22, 31]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [4, 6, 16, 21]},\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [9, 10]}\n    ],\n    \"complexes\": [\"virus-like particle\", \"stress granule\"],\n    \"partners\": [\"SIAH1\", \"SIAH2\", \"UBQLN2\", \"UBE3A\", \"USP9X\", \"TSG101\", \"RTL8\", \"ATXN2\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":8,"faith_pct":87.5}}